Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables RefundsShares IssuedShares OutstandingShares Outstanding
Ratios

Airsculpt Technologies (AIRS) Long-Term Debt Issuances (2021 - 2022)

Airsculpt Technologies recorded quarterly Long-Term Debt Issuances of $83.5 million in Q4 2022, up 21456.27% quarter-over-quarter from -$391000.0 in Q4 2021, and up 21456.27% year-over-year from N/an in Q4 2021.

Airsculpt Technologies' Long-Term Debt Issuances history runs 2 years deep, the most recent figure standing at $83.5 million for Q4 2022.

  • In Q4 2022, Long-Term Debt Issuances rose 21456.27% year-over-year to $83.5 million; the TTM figure through Dec 2022 stood at $83.1 million (changed N/A YoY), while the FY2022 annual figure was $83.5 million, up 68.34% from the prior year.
  • Long-Term Debt Issuances came in at $83.5 million for Q4 2022 at Airsculpt Technologies, up from -$391000.0 in the prior quarter.
  • In the past five years, Long-Term Debt Issuances ranged from a high of $83.5 million in Q4 2022 to a low of -$391000.0 in Q4 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Debt Issuances (Qtr)
1 HCA Healthcare 84.64 Bn 87.02 Bn 16.26 Bn -
2 Tenet Healthcare 15.22 Bn 14.39 Bn 4.41 Bn 14.00 Mn
3 Davita 13.10 Bn 13.96 Bn 1.07 Bn 1.26 Bn
4 Encompass Health 10.50 Bn 11.12 Bn 1.34 Bn 250.00 Mn
5 Ensign 9.69 Bn 9.09 Bn 293.37 Mn -
6 Universal Health Services 8.92 Bn 8.88 Bn 3.21 Bn -
7 Fresenius Medical Care AG 7.31 Bn 4.93 Bn 22,843.10 Bn 582.91 Mn
8 Chemed 5.83 Bn 5.81 Bn 215.76 Mn 135.48 Mn
9 Pacs 5.76 Bn 5.51 Bn 345.96 Mn -
10 Airsculpt Technologies 373.70 Mn 357.01 Mn 23.80 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2022 83.50 Mn
Dec 31, 2022 83.50 Mn
Dec 31, 2021 -391,000.00
Dec 31, 2021 -391,000.00
Sep 30, 2021 -1,000.00
Sep 30, 2021 -1,000.00